As Executive Vice President, Chief Legal & Regulatory Officer, Daan leads Legal Affairs, Regulatory Affairs, Quality Assurance, Risk & Compliance, and Information Security at SOPHiA GENETICS. With over 25 years of experience in top-tier private practice, in-house, and consulting roles, Daan brings extensive expertise in legal, governance, and compliance.
Daan joined SOPHiA GENETICS in June 2019 as General Counsel. Before this role, he served as Head of Legal Services at PwC in Geneva, where he advised on business process optimization, commercial transactions, mergers and acquisitions, business development, governance, and compliance. Prior to PwC, Daan was Group Corporate Secretary at international food retailer Ahold (now Ahold Delhaize), where he oversaw corporate finance, governance, and investor relations for the New York Stock Exchange- and AEX Euronext Amsterdam-listed company.
He began his career at the top-tier international law firm Loyens & Loeff in Rotterdam, The Netherlands, where he gained a strong foundation in corporate law and regulatory matters.
Daan holds an LL.M. in Civil Law from Utrecht University and an Executive M.B.A. in Management and Corporate Finance from HEC Lausanne.
What is Well Daan Van's net worth?
The estimated net worth of Well Daan Van is at least $1.76 million as of April 20th, 2026. Van owns 345,736 shares of SOPHiA GENETICS stock worth more than $1,760,142 as of May 5th. This net worth evaluation does not reflect any other investments that Van may own. Learn More about Well Daan Van's net worth.
How do I contact Well Daan Van?
Has Well Daan Van been buying or selling shares of SOPHiA GENETICS?
Within the last three months, Well Daan Van has sold $51,210.07 of SOPHiA GENETICS stock. Most recently, Well Daan Van sold 684 shares of the business's stock in a transaction on Monday, April 20th. The shares were sold at an average price of $5.20, for a transaction totalling $3,556.80. Following the completion of the sale, the insider now directly owns 345,736 shares of the company's stock, valued at $1,797,827.20. Learn More on Well Daan Van's trading history.
Who are SOPHiA GENETICS's active insiders?
SOPHiA GENETICS's insider roster includes Jurgi Camblong (Founder and CEO), George Cardoza (EVP – Chief Financial Officer), Philippe Menu (Insider), Ross Muken (President), Kevin Puylaert (SVP, Chief Sales Officer), Manuela Valente (Insider), Well Van (Insider), Abhimanyu Verma (EVP, Chief Technology Officer), and Zhenyu Xu (Insider). Learn More on SOPHiA GENETICS's active insiders.
Are insiders buying or selling shares of SOPHiA GENETICS?
In the last twelve months, insiders at the sold shares 57 times. They sold a total of 193,859 shares worth more than $943,777.03. The most recent insider tranaction occured on April, 27th when insider Philippe Menu sold 5,000 shares worth more than $24,100.00. Insiders at SOPHiA GENETICS own 4.9% of the company.
Learn More about insider trades at SOPHiA GENETICS. Information on this page was last updated on 4/27/2026.
